| Institutions |
Authors |
Share |
|
Boehringer Ingelheim Pharma GmbH & Co. KG, Germany
|
1.500000
|
0.11 |
|
Boehringer Ingelheim International GmbH, Germany
|
1.500000
|
0.11 |
|
Baylor Scott & White Health, United States of America (USA)
|
1.000000
|
0.07 |
|
National and Kapodistrian University of Athens (UOA), Greece
|
1.000000
|
0.07 |
|
Mainanalytics GmbH, Germany
|
1.000000
|
0.07 |
|
University Medical Center Mainz, JGU, Germany
|
1.000000
|
0.07 |
|
London School of Hygiene and Tropical Medicine (LSHTM), United Kingdom (UK)
|
1.000000
|
0.07 |
|
University of Glasgow, United Kingdom (UK)
|
1.000000
|
0.07 |
|
Centre d'Investigation Clinique - Epidémiologie Clinique (CIC-EC 1433), France
|
0.533333
|
0.04 |
|
Investigation Network Initiative-Cardiovascular and Renal Clinical Trialists (INI-CRCT), F-CRIN, France
|
0.533333
|
0.04 |
|
Défaillance Cardio-Vasculaire Aigüe et Chronique (DCAC), France
|
0.533333
|
0.04 |
|
University of Mississippi (Ole Miss), United States of America (USA)
|
0.500000
|
0.04 |
|
Baim Institute for Clinical Research, United States of America (USA)
|
0.500000
|
0.04 |
|
Baylor Scott & White Heart and Vascular Hospital, United States of America (USA)
|
0.500000
|
0.04 |
|
Imperial College London (ICL), United Kingdom (UK)
|
0.500000
|
0.04 |
|
Berlin-Brandenburg Center for Regenerative Therapies (BCRT), Germany
|
0.333333
|
0.02 |
|
DZHK Partner Site Berlin, Germany
|
0.333333
|
0.02 |
|
Wroclaw Medical University, Poland
|
0.333333
|
0.02 |
|
University of Porto (UP), Portugal
|
0.200000
|
0.01 |
|
Centro Hospitalar de Vila Nova de Gaia/Espinho (CHVNG/E), Portugal
|
0.200000
|
0.01 |
